<?xml version="1.0" encoding="UTF-8" ?><rss version="2.0">
	<channel>
	    <title><![CDATA[Degenerative Neurological and Neuromuscular Disease]]></title>
	    <description><![CDATA[Degenerative Neurological and Neuromuscular Disease is an international, peer-reviewed, open access journal focusing on research into degenerative neurological and neuromuscular disease, identification of therapeutic targets and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the patient. ]]></description>
	    <link>http://dovepress.com/degenerative-neurological-and-neuromuscular-disease-journal</link>
	    				<item>
					<title><![CDATA[Behavioral assessment of visual deficits in the taiep mutant]]></title>
					<description><![CDATA[Bloom CM, Post RJ, Anch AM, Davenport DG]]></description>
					<link>http://dovepress.com/behavioral-assessment-of-visual-deficits-in-the-taiep-mutant-peer-reviewed-article-DNND</link>
					<guid isPermaLink="true">http://dovepress.com/behavioral-assessment-of-visual-deficits-in-the-taiep-mutant-peer-reviewed-article-DNND</guid>
				</item>
	    				<item>
					<title><![CDATA[The relationship between the apolipoprotein E e4 allele and hippocampal magnetic resonance imaging volume in community-dwelling individuals with mild Alzheimer&#39;s disease]]></title>
					<description><![CDATA[Walsh B, Slater S, Nair B, Attia J]]></description>
					<link>http://dovepress.com/the-relationship-between-the-apolipoprotein-e-e4-allele-and-hippocampa-peer-reviewed-article-DNND</link>
					<guid isPermaLink="true">http://dovepress.com/the-relationship-between-the-apolipoprotein-e-e4-allele-and-hippocampa-peer-reviewed-article-DNND</guid>
				</item>
	    				<item>
					<title><![CDATA[The pharmacologic management of depression in Parkinson&#39;s disease]]></title>
					<description><![CDATA[Schreiber MA, Thompson AW]]></description>
					<link>http://dovepress.com/the-pharmacologic-management-of-depression-in-parkinson39s-disease-peer-reviewed-article-DNND</link>
					<guid isPermaLink="true">http://dovepress.com/the-pharmacologic-management-of-depression-in-parkinson39s-disease-peer-reviewed-article-DNND</guid>
				</item>
	    				<item>
					<title><![CDATA[Pathogenic mechanisms of neurodegeneration based on the phenotypic expression of progressive forms of immune-mediated neurologic disease]]></title>
					<description><![CDATA[Levin MC, Lee S, Gardner LA, Shin Y, Douglas JN, Groover CJ]]></description>
					<link>http://dovepress.com/pathogenic-mechanisms-of-neurodegeneration-based-on-the-phenotypic-exp-peer-reviewed-article-DNND</link>
					<guid isPermaLink="true">http://dovepress.com/pathogenic-mechanisms-of-neurodegeneration-based-on-the-phenotypic-exp-peer-reviewed-article-DNND</guid>
				</item>
	    				<item>
					<title><![CDATA[Evaluation of tafamidis as first-line therapeutic agent for transthyretin familial amyloidotic polyneuropathy]]></title>
					<description><![CDATA[Buxbaum JN]]></description>
					<link>http://dovepress.com/evaluation-of-tafamidis-as-first-line-therapeutic-agent-for-transthyre-peer-reviewed-article-DNND</link>
					<guid isPermaLink="true">http://dovepress.com/evaluation-of-tafamidis-as-first-line-therapeutic-agent-for-transthyre-peer-reviewed-article-DNND</guid>
				</item>
	    				<item>
					<title><![CDATA[Recent advances in Duchenne muscular dystrophy]]></title>
					<description><![CDATA[Perkins KJ, Davies KE]]></description>
					<link>http://dovepress.com/recent-advances-in-duchenne-muscular-dystrophy-peer-reviewed-article-DNND</link>
					<guid isPermaLink="true">http://dovepress.com/recent-advances-in-duchenne-muscular-dystrophy-peer-reviewed-article-DNND</guid>
				</item>
	    				<item>
					<title><![CDATA[Optimal management for people with severe spasticity]]></title>
					<description><![CDATA[Shilt JS, Seibert PS, Kadyan V]]></description>
					<link>http://dovepress.com/optimal-management-for-people-with-severe-spasticity-peer-reviewed-article-DNND</link>
					<guid isPermaLink="true">http://dovepress.com/optimal-management-for-people-with-severe-spasticity-peer-reviewed-article-DNND</guid>
				</item>
	    				<item>
					<title><![CDATA[BG-12 and its potential for the prevention of relapse in multiple sclerosis]]></title>
					<description><![CDATA[Giannetti P, Niccolini F, Nicholas R]]></description>
					<link>http://dovepress.com/bg-12-and-its-potential-for-the-prevention-of-relapse-in-multiple-scle-peer-reviewed-article-DNND</link>
					<guid isPermaLink="true">http://dovepress.com/bg-12-and-its-potential-for-the-prevention-of-relapse-in-multiple-scle-peer-reviewed-article-DNND</guid>
				</item>
	    				<item>
					<title><![CDATA[Deep brain stimulation for the treatment of Parkinson&rsquo;s disease: efficacy and safety]]></title>
					<description><![CDATA[Pouratian N, Thakkar S, Kim W, Bronstein JM]]></description>
					<link>http://dovepress.com/deep-brain-stimulation-for-the-treatment-of-parkinsonrsquos-disease-ef-peer-reviewed-article-DNND</link>
					<guid isPermaLink="true">http://dovepress.com/deep-brain-stimulation-for-the-treatment-of-parkinsonrsquos-disease-ef-peer-reviewed-article-DNND</guid>
				</item>
	    				<item>
					<title><![CDATA[New insights into the clinical evaluation of hereditary transthyretin amyloidosis patients: a single center&#39;s experience]]></title>
					<description><![CDATA[Suhr OB, Gustavsson S, Heldestad V, H&ouml;rnsten R, Lindqvist P, Nordh E, Wiklund U]]></description>
					<link>http://dovepress.com/new-insights-into-the-clinical-evaluation-of-hereditary-transthyretin--peer-reviewed-article-DNND</link>
					<guid isPermaLink="true">http://dovepress.com/new-insights-into-the-clinical-evaluation-of-hereditary-transthyretin--peer-reviewed-article-DNND</guid>
				</item>
	    				<item>
					<title><![CDATA[Stem cells and regenerative therapies for Parkinson&rsquo;s disease]]></title>
					<description><![CDATA[Farrell K, Barker RA]]></description>
					<link>http://dovepress.com/stem-cells-and-regenerative-therapies-for-parkinsonrsquos-disease-peer-reviewed-article-DNND</link>
					<guid isPermaLink="true">http://dovepress.com/stem-cells-and-regenerative-therapies-for-parkinsonrsquos-disease-peer-reviewed-article-DNND</guid>
				</item>
	    				<item>
					<title><![CDATA[Cell adhesion molecules in Alzheimer&#39;s disease]]></title>
					<description><![CDATA[Wennstr&ouml;m M, Nielsen HM]]></description>
					<link>http://dovepress.com/cell-adhesion-molecules-in-alzheimer39s-disease-peer-reviewed-article-DNND</link>
					<guid isPermaLink="true">http://dovepress.com/cell-adhesion-molecules-in-alzheimer39s-disease-peer-reviewed-article-DNND</guid>
				</item>
	    				<item>
					<title><![CDATA[Walking impairment in patients with multiple sclerosis &ndash; a new therapeutic approach and clinical potential of dalfampridine extended release tablets]]></title>
					<description><![CDATA[Henney III HR, Blight AR]]></description>
					<link>http://dovepress.com/walking-impairment-in-patients-with-multiple-sclerosis-ndash-a-new-the-peer-reviewed-article-DNND</link>
					<guid isPermaLink="true">http://dovepress.com/walking-impairment-in-patients-with-multiple-sclerosis-ndash-a-new-the-peer-reviewed-article-DNND</guid>
				</item>
	    				<item>
					<title><![CDATA[Inclusion body myositis: therapeutic approaches]]></title>
					<description><![CDATA[Aggarwal R, Oddis CV]]></description>
					<link>http://dovepress.com/inclusion-body-myositis-therapeutic-approaches-peer-reviewed-article-DNND</link>
					<guid isPermaLink="true">http://dovepress.com/inclusion-body-myositis-therapeutic-approaches-peer-reviewed-article-DNND</guid>
				</item>
	    				<item>
					<title><![CDATA[Update on pediatric dystonias: etiology, epidemiology, and management]]></title>
					<description><![CDATA[Fern&aacute;ndez-Alvarez E, Nardocci N]]></description>
					<link>http://dovepress.com/update-on-pediatric-dystonias-etiology-epidemiology-and-management-peer-reviewed-article-DNND</link>
					<guid isPermaLink="true">http://dovepress.com/update-on-pediatric-dystonias-etiology-epidemiology-and-management-peer-reviewed-article-DNND</guid>
				</item>
	    				<item>
					<title><![CDATA[Emerging oral immunomodulating agents &ndash; focus on teriflunomide for the treatment of multiple sclerosis]]></title>
					<description><![CDATA[Nwankwo E, Allington DR, Rivey MP]]></description>
					<link>http://dovepress.com/emerging-oral-immunomodulating-agents-ndash-focus-on-teriflunomide-for-peer-reviewed-article-DNND</link>
					<guid isPermaLink="true">http://dovepress.com/emerging-oral-immunomodulating-agents-ndash-focus-on-teriflunomide-for-peer-reviewed-article-DNND</guid>
				</item>
	    				<item>
					<title><![CDATA[Amyotrophic lateral sclerosis: update and new developments]]></title>
					<description><![CDATA[Pratt AJ, Getzoff ED, Perry JJ]]></description>
					<link>http://dovepress.com/amyotrophic-lateral-sclerosis-update-and-new-developments-peer-reviewed-article-DNND</link>
					<guid isPermaLink="true">http://dovepress.com/amyotrophic-lateral-sclerosis-update-and-new-developments-peer-reviewed-article-DNND</guid>
				</item>
	    				<item>
					<title><![CDATA[Therapeutic application of monoclonal antibodies in multiple sclerosis: focus on alemtuzumab]]></title>
					<description><![CDATA[Niino M]]></description>
					<link>http://dovepress.com/therapeutic-application-of-monoclonal-antibodies-in-multiple-sclerosis-peer-reviewed-article-DNND</link>
					<guid isPermaLink="true">http://dovepress.com/therapeutic-application-of-monoclonal-antibodies-in-multiple-sclerosis-peer-reviewed-article-DNND</guid>
				</item>
	    				<item>
					<title><![CDATA[Profile of oral laquinimod and its potential in the treatment of multiple sclerosis]]></title>
					<description><![CDATA[West MS, Miravalle A]]></description>
					<link>http://dovepress.com/profile-of-oral-laquinimod-and-its-potential-in-the-treatment-of-multi-peer-reviewed-article-DNND</link>
					<guid isPermaLink="true">http://dovepress.com/profile-of-oral-laquinimod-and-its-potential-in-the-treatment-of-multi-peer-reviewed-article-DNND</guid>
				</item>
	    				<item>
					<title><![CDATA[Emerging treatment options for spasticity in multiple sclerosis &ndash; clinical utility of cannabinoids]]></title>
					<description><![CDATA[Ashton JC]]></description>
					<link>http://dovepress.com/emerging-treatment-options-for-spasticity-in-multiple-sclerosis-ndash--peer-reviewed-article-DNND</link>
					<guid isPermaLink="true">http://dovepress.com/emerging-treatment-options-for-spasticity-in-multiple-sclerosis-ndash--peer-reviewed-article-DNND</guid>
				</item>
	    				<item>
					<title><![CDATA[Critical appraisal and role of memantine extended-release in the management of Alzheimer&rsquo;s disease]]></title>
					<description><![CDATA[Singh I, Grossberg GT]]></description>
					<link>http://dovepress.com/critical-appraisal-and-role-of-memantine-extended-release-in-the-manag-peer-reviewed-article-DNND</link>
					<guid isPermaLink="true">http://dovepress.com/critical-appraisal-and-role-of-memantine-extended-release-in-the-manag-peer-reviewed-article-DNND</guid>
				</item>
	    				<item>
					<title><![CDATA[Evaluation of glycopyrrolate in the treatment of chronic drooling]]></title>
					<description><![CDATA[Reddihough DS, Reid SM, Plover C]]></description>
					<link>http://dovepress.com/evaluation-of-glycopyrrolate-in-the-treatment-of-chronic-drooling-peer-reviewed-article-DNND</link>
					<guid isPermaLink="true">http://dovepress.com/evaluation-of-glycopyrrolate-in-the-treatment-of-chronic-drooling-peer-reviewed-article-DNND</guid>
				</item>
	    				<item>
					<title><![CDATA[Editorial]]></title>
					<description><![CDATA[Glenn Lopate]]></description>
					<link>http://dovepress.com/editorial-the-proposition-to-start-a-new-journal-peer-reviewed-article-DNND</link>
					<guid isPermaLink="true">http://dovepress.com/editorial-the-proposition-to-start-a-new-journal-peer-reviewed-article-DNND</guid>
				</item>
	        </channel>
</rss>